Abstract
Immunoglobulin class switch recombination deficiencies (Ig-CSR-D) are characterized by normal or elevated serum IgM level and absence of IgG, IgA, and IgE. Most reported cases are due to X-linked CD40L deficiency. Activation-induced cytidine deaminase deficiency is the most frequent autosomal recessive form, whereas CD40 deficiency is more rare. Herein, we present the first North African study on hyper IgM (HIGM) syndrome including 16 Tunisian patients. Phenotypic and genetic studies allowed us to determine their molecular basis. Three CD40LG mutations have been identified including two novels (c.348_351dup and c.782_*2del) and one already reported mutation (g.6182G>A). No mutation has been found in another patient despite the lack of CD40L expression. Interestingly, three AICDA mutations have been identified in 11 patients. Two mutations were novel (c.91T>C and c.389A>C found in one and five patients respectively), and one previously reported splicing mutation (c.156 + 1T>G) was found in five patients. Only one CD40-deficient patient, bearing a novel mutation (c.109T>G), has been identified. Thus, unlike previous reports, AID deficiency is the most frequent underlying molecular basis (68 %) of Ig-CSR-D in Tunisian patients. This finding and the presence of specific recurrent mutations are probably due to the critical role played by inbreeding in North African populations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Achkar JM, Casadevall A (2013) Antibody-mediated immunity against tuberculosis: implications for vaccine development. Cell Host Microbe 13:250–262. doi:10.1016/j.chom.2013.02.009
Adzhubei IA, Schmidt S, Peshkin L et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248–249. doi:10.1038/nmeth0410-248
Aghamohammadi A, Parvaneh N, Rezaei N et al (2009) Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations. J Clin Immunol 29:769–776. doi:10.1007/s10875-009-9315-7
Allen RC, Armitage RJ, Conley ME et al (1993) CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990–993
Al-Saud BK, Al-Sum Z, Alassiri H et al (2013) Clinical, immunological, and molecular characterization of hyper-IgM syndrome due to CD40 deficiency in eleven patients. J Clin Immunol 33:1325–1335. doi:10.1007/s10875-013-9951-9
Aruffo A, Farrington M, Hollenbaugh D et al (1993) The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72:291–300
Bajorath J, Chalupny NJ, Marken JS et al (1995a) Identification of residues on CD40 and its ligand which are critical for the receptor-ligand interaction. Biochemistry 34:1833–1844
Bajorath J, Marken JS, Chalupny NJ et al (1995b) Analysis of gp39/CD40 interactions using molecular models and site-directed mutagenesis. Biochemistry 34:9884–9892
Barbouche M-R, Galal N, Ben-Mustapha I et al (2011) Primary immunodeficiencies in highly consanguineous North African populations. Ann NY Acad Sci 1238:42–52. doi:10.1111/j.1749-6632.2011.06260.x
Bejaoui M, Mellouli F, Chouanine R et al (2003) The hyper-IgM syndrome: 13 observations. Presse Med 32:544–549
Ben-Mustapha I, Ben-Farhat K, Guirat-Dhouib N et al (2013) Clinical, immunological and genetic findings of a large Tunisian series of major histocompatibility complex class II deficiency patients. J Clin Immunol 33:865–870. doi:10.1007/s10875-013-9863-8
Ben-Mustapha I, Ben-Ali M, Mekki N et al (2014) A 1,100-year-old founder effect mutation in IL12B gene is responsible for Mendelian susceptibility to mycobacterial disease in Tunisian patients. Immunogenetics 66:67–71. doi:10.1007/s00251-013-0739-0
BenMustapha-Darghouth I, Trabelsi S, Largueche B et al (2007) Prévalence de la pneumopathie à Pneumocystis Jiroveci au cours des déficits immunitaires héréditaires observés en Tunisie. Arch Pédiatr 14:20–23. doi:10.1016/j.arcped.2006.10.012
Cabral-Marques O, Klaver S, Schimke LF et al (2014) First report of the hyper-IgM syndrome registry of the Latin American Society for immunodeficiencies: novel mutations, unique infections, and outcomes. J Clin Immunol 34:146–156. doi:10.1007/s10875-013-9980-4
Casadevall A (2003) Antibody-mediated immunity against intracellular pathogens: two-dimensional thinking comes full circle. Infect Immun 71:4225–4228
Davies EG, Thrasher AJ (2010) Update on the hyper immunoglobulin M syndromes. Br J Haematol 149:167–180. doi:10.1111/j.1365-2141.2010.08077.x
DiSanto JP, Bonnefoy JY, Gauchat JF et al (1993) CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361:541–543. doi:10.1038/361541a0
Durandy A, Kracker S (2012) Immunoglobulin class-switch recombination deficiencies. Arthritis Res Ther 14:218. doi:10.1186/ar3904
Durandy A, Peron S, Taubenheim N, Fischer A (2006) Activation-induced cytidine deaminase: structure-function relationship as based on the study of mutants. Hum Mutat 27:1185–1191. doi:10.1002/humu.20414
Durandy A, Kracker S, Fischer A (2013) Primary antibody deficiencies. Nat Rev Immunol 13:519–533. doi:10.1038/nri3466
El Kares R, Barbouche MR, Elloumi-Zghal H et al (2006) Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia. J Hum Genet 51:887–895. doi:10.1007/s10038-006-0039-8
Ferrari S, Giliani S, Insalaco A et al (2001) Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci U S A 98:12614–12619. doi:10.1073/pnas.221456898
Fiorini C, Jilani S, Losi CG et al (2004) A novel activation-induced cytidine deaminase gene mutation in a Tunisian family with hyper IgM syndrome. Eur J Pediatr 163:704–708. doi:10.1007/s00431-004-1540-8
Fokkema IFAC, Taschner PEM, Schaafsma GCP et al (2011) LOVD v. 2.0: the next generation in gene variant databases. Hum Mutat 32:557–563. doi:10.1002/humu.21438
Gathmann B, Binder N, Ehl S, Kindle G (2012) The European internet-based patient and research database for primary immunodeficiencies: update 2011. Clin Exp Immunol 167:479–491. doi:10.1111/j.1365-2249.2011.04542.x
He B, Xu W, Santini PA et al (2007) Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. Immunity 26:812–826. doi:10.1016/j.immuni.2007.04.014
Hu Y, Ericsson I, Torseth K et al (2013) A combined nuclear and nucleolar localization motif in activation-induced cytidine deaminase (AID) controls immunoglobulin class switching. J Mol Biol 425:424–443. doi:10.1016/j.jmb.2012.11.026
Imai K, Catalan N, Plebani A et al (2003a) Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J Clin Invest 112:136–142. doi:10.1172/JCI18161
Imai K, Slupphaug G, Lee W-I et al (2003b) Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 4:1023–1028. doi:10.1038/ni974
Jain A, Ma CA, Liu S et al (2001) Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia. Nat Immunol 2:223–228. doi:10.1038/85277
Karaca NE, Forveille M, Aksu G et al (2012) Hyper-immunoglobulin M syndrome type 3 with normal CD40 cell surface expression. Scand J Immunol 76:21–25. doi:10.1111/j.1365-3083.2012.02697.x
Klug-Micu GM, Stenger S, Sommer A et al (2013) CD40 ligand and interferon-γ induce an antimicrobial response against Mycobacterium tuberculosis in human monocytes. Immunology 139:121–128. doi:10.1111/imm.12062
Kong J, Liebhaber SA (2007) A cell type-restricted mRNA surveillance pathway triggered by ribosome extension into the 3’ untranslated region. Nat Struct Mol Biol 14:670–676. doi:10.1038/nsmb1256
Korthäuer U, Graf D, Mages HW et al (1993) Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539–541. doi:10.1038/361539a0
Kracker S, Imai K, Gardès P et al (2010) Impaired induction of DNA lesions during immunoglobulin class-switch recombination in humans influences end-joining repair. Proc Natl Acad Sci U S A 107:22225–22230. doi:10.1073/pnas.1012591108
Kumar P, Henikoff S, Ng PC (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4:1073–1081. doi:10.1038/nprot.2009.86
Laughlin J, Oghlidos S, Porter JF et al (2008) Functional analysis of a tripartite stability element within the CD40 ligand 3’ untranslated region. Immunology 124:368–379. doi:10.1111/j.1365-2567.2007.02783.x
Lee W-I, Torgerson TR, Schumacher MJ et al (2005) Molecular analysis of a large cohort of patients with the hyper immunoglobulin M (IgM) syndrome. Blood 105:1881–1890. doi:10.1182/blood-2003-12-4420
Lee W-I, Huang J-L, Yeh K-W et al (2011) Immune defects in active mycobacterial diseases in patients with primary immunodeficiency diseases (PIDs). J Formos Med Assoc 110:750–758. doi:10.1016/j.jfma.2011.11.004
Levy J, Espanol-Boren T, Thomas C et al (1997) Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 131:47–54
Lobo FM, Xu S, Lee C, Fuleihan RL (2000) Transcriptional activity of the distal CD40 ligand promoter. Biochem Biophys Res Commun 279:245–250. doi:10.1006/bbrc.2000.3914
Madkaikar M, Gupta M, Chavan S et al (2014) X-linked hyper IgM syndrome: clinical, immunological and molecular features in patients from India. Blood Cells Mol Dis 53:99–104. doi:10.1016/j.bcmd.2014.05.008
Marovich MA, McDowell MA, Thomas EK, Nutman TB (2000) IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process. J Immunol 164:5858–5865
Martín JC, Sancho T, Sierra FJ et al (1996) Visceral leishmaniasis in a patient with hyper-IgM hypogammaglobulinemia. Clin Infect Dis 23:1188–1189
Minegishi Y, Lavoie A, Cunningham-Rundles C et al (2000) Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clin Immunol 97:203–210. doi:10.1006/clim.2000.4956
Notarangelo LD, Duse M, Ugazio AG (1992) Immunodeficiency with hyper-IgM (HIM). Immunodefic Rev 3:101–121
Patenaude A-M, Orthwein A, Hu Y et al (2009) Active nuclear import and cytoplasmic retention of activation-induced deaminase. Nat Struct Mol Biol 16:517–527. doi:10.1038/nsmb.1598
Peitsch MC, Tschopp J (1995) Comparative molecular modelling of the Fas-ligand and other members of the TNF family. Mol Immunol 32:761–772
Péron S, Metin A, Gardès P et al (2008) Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination. J Exp Med 205:2465–2472. doi:10.1084/jem.20080789
Qamar N, Fuleihan RL (2014) The hyper IgM syndromes. Clin Rev Allergy Immunol 46:120–130. doi:10.1007/s12016-013-8378-7
Quartier P, Bustamante J, Sanal O et al (2004) Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol 110:22–29. doi:10.1016/j.clim.2003.10.007
Revy P, Muto T, Levy Y et al (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102:565–575
Romdhane L, Kefi R, Azaiez H et al (2012) Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East. Orphanet J Rare Dis 7:52. doi:10.1186/1750-1172-7-52
Seyama K, Nonoyama S, Gangsaas I et al (1998) Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 92:2421–2434
Silva R, Da Costa JT (2010) Hyper-IgM syndrome—a case report and a clinical perspective. Eur Ann Allergy Clin Immunol 42:194–196
Steingart KR, Dendukuri N, Henry M et al (2009) Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clin Vaccine Immunol 16:260–276. doi:10.1128/CVI.00355-08
Van Kooten C, Banchereau J (2000) CD40-CD40 ligand. J Leukoc Biol 67:2–17
Wilson EH, Hunter CA (2003) Understanding the role of the CD40–CD40L interaction in resistance to parasitic infections. Parasite Immunol 25:179–183
Zhu X, Chung I, O’Gorman MR, Scholl PR (2001) Coexpression of normal and mutated CD40 ligand with deletion of a putative RNA lariat branchpoint sequence in X-linked hyper-IgM syndrome. Clin Immunol 99:334–339. doi:10.1006/clim.2001.5022
Zhu Y, Nonoyama S, Morio T et al (2003) Type two hyper-IgM syndrome caused by mutation in activation-induced cytidine deaminase. J Med Dent Sci 50:41–46
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 15 kb)
Rights and permissions
About this article
Cite this article
Ouadani, H., Ben-Mustapha, I., Ben-ali, M. et al. Novel and recurrent AID mutations underlie prevalent autosomal recessive form of HIGM in consanguineous patients. Immunogenetics 68, 19–28 (2016). https://doi.org/10.1007/s00251-015-0878-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00251-015-0878-6